You can buy or sell Trevena and other stocks, options, ETFs, and crypto commission-free!
Trevena, Inc. Common Stock, also called Trevena, is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. Read More The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.
52 Week High
52 Week Low
Expected Nov 7, Pre-Market